— Know what they know.
Not Investment Advice
Also trades as: 0R2M.L (LSE) · $vol 1M

REGN NASDAQ

Regeneron Pharmaceuticals, Inc.
1W: -9.8% 1M: -14.0% 3M: -17.6% YTD: -17.1% 1Y: +4.8% 3Y: -13.0% 5Y: +25.0%
$638.88
-3.71 (-0.58%)
 
Weekly Expected Move ±4.6%
$634 $666 $698 $730 $763
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 36 · $65.8B mcap · 101M float · 0.747% daily turnover · Short 24% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.9 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 12.3%  ·  5Y Avg: 27.5%
Cost Advantage
58
Intangibles
38
Switching Cost
57
Network Effect
45
Scale ★
65
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. REGN shows a Weak competitive edge (51.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 12.3% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$641
Low
$814
Avg Target
$995
High
Based on 12 analysts since Apr 29, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 32Hold: 16Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$827.78
Analysts18
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-19 Canaccord Genuity John Newman $1057 $875 -182 +39.0% $629.68
2026-05-18 Wolfe Research Alexandria Hammond Initiated $860 +36.6% $629.36
2026-05-18 Evercore ISI $875 $825 -50 +33.1% $619.84
2026-05-18 RBC Capital $765 $707 -58 +14.1% $619.62
2026-05-18 Truist Financial $796 $778 -18 +25.5% $619.95
2026-05-18 BMO Capital $850 $730 -120 +4.5% $698.25
2026-05-18 Piper Sandler $1195 $855 -340 +22.4% $698.25
2026-05-18 Leerink Partners Market Perform $873 $641 -232 -8.2% $698.25
2026-05-01 Guggenheim Yatin Suneja $975 $995 +20 +40.7% $707.06
2026-04-30 Morgan Stanley Terence Flynn $796 $788 -8 +12.1% $703.18
2026-04-30 Truist Financial $818 $796 -22 +14.9% $692.75
2026-04-30 Barclays $923 $917 -6 +33.6% $686.36
2026-04-22 Raymond James Chris Raymond $870 $910 +40 +21.9% $746.58
2026-04-10 Morgan Stanley $769 $796 +27 +6.7% $746.15
2026-04-08 Bernstein $916 $921 +5 +18.8% $775.53
2026-03-09 Truist Financial Greg Renza $798 $818 +20 +6.2% $770.32
2026-03-06 Barclays Eliana Merle $815 $923 +108 +20.7% $764.93
2026-03-02 RBC Capital Brian Abrahams $745 $765 +20 -2.4% $784.06
2026-02-09 Guggenheim $865 $975 +110 +24.1% $785.51
2026-02-02 Cantor Fitzgerald Carter Gould $740 $800 +60 +5.6% $757.59
2026-02-02 Robert W. Baird Brian Skorney $637 $742 +105 -1.8% $755.34
2026-02-02 Oppenheimer Initiated $865 +16.7% $741.45
2026-02-02 Tudor Pickering William Pickering $916 $925 +9 +22.8% $753.13
2026-02-01 Morgan Stanley Terence Flynn $768 $769 +1 +3.7% $741.45
2026-01-30 Raymond James $723 $870 +147 +17.3% $741.45
2026-01-27 Tudor Pickering William Pickering Initiated $916 +20.2% $762.10
2026-01-27 RBC Capital Brian Abrahams $708 $745 +37 -3.1% $769.05
2026-01-27 Bernstein $818 $916 +98 +20.1% $762.65
2026-01-22 Evercore ISI $1170 $875 -295 +14.9% $761.56
2026-01-08 Goldman Sachs $1292 $914 -378 +12.5% $812.27
2025-12-17 Leerink Partners Andrew Berens $880 $873 -7 +17.0% $746.36
2025-12-12 Morgan Stanley Terence Flynn $767 $768 +1 +3.6% $741.51
2025-12-10 HSBC $890 $985 +95 +42.2% $692.58
2025-12-04 BMO Capital Evan Seigerman $725 $850 +125 +17.5% $723.67
2025-12-04 Canaccord Genuity $850 $1057 +207 +46.1% $723.67
2025-11-24 Truist Financial $1200 $798 -402 +4.1% $766.50
2025-11-24 Scotiabank Initiated $770 +0.1% $769.23
2025-11-24 HSBC Initiated $890 +17.7% $755.90
2025-11-20 Wells Fargo Mohit Bansal $615 $700 +85 -0.4% $702.75
2025-10-29 RBC Capital $1282 $708 -574 +8.4% $653.01
2025-10-29 Cantor Fitzgerald Carter Gould $695 $740 +45 +12.6% $657.00
2025-10-29 BMO Capital Evan Seigerman $640 $725 +85 +10.8% $654.48
2025-10-29 Wells Fargo $1050 $615 -435 -6.0% $654.48
2025-10-29 Robert W. Baird $630 $637 +7 -1.4% $645.93
2025-10-29 Bernstein $660 $818 +158 +25.0% $654.42
2025-10-29 Guggenheim $1180 $865 -315 +32.2% $654.48
2025-10-29 Robert W. Baird Brian Skorney $940 $630 -310 -3.7% $654.48
2025-10-28 Raymond James Christopher Raymond $673 $723 +50 +10.5% $654.48
2025-10-28 Morgan Stanley $756 $767 +11 +17.2% $654.48
2025-10-10 Morgan Stanley $754 $756 +2 +32.9% $568.81

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
May 22, 2026
DCF
5
ROE
4
ROA
5
D/E
3
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. REGN receives an overall rating of A. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5). Areas of concern: P/E (2/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

71 Grade A+
Profitability
70
Balance Sheet
96
Earnings Quality
69
Growth
43
Value
65
Momentum
69
Safety
100
Cash Flow
88
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. REGN scores highest in Safety (100/100) and lowest in Growth (43/100). An overall grade of A+ places REGN among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
7.80
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.47
Unlikely Manipulator
Ohlson O-Score
-11.58
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 96.8/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.13x
Accruals: -1.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. REGN scores 7.80, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. REGN scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. REGN's score of -2.47 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. REGN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. REGN receives an estimated rating of AAA (score: 96.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). REGN's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.02x
PEG
8.15x
P/S
4.41x
P/B
2.11x
P/FCF
20.03x
P/OCF
16.60x
EV/EBITDA
13.46x
EV/Revenue
5.18x
EV/EBIT
14.85x
EV/FCF
18.61x
Earnings Yield
5.32%
FCF Yield
4.99%
Shareholder Yield
4.99%
Graham Number
$517.88
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.0x earnings, REGN trades at a reasonable valuation. An earnings yield of 5.3% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $517.88 per share, 23% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.858
NI / EBT
×
Interest Burden
0.991
EBT / EBIT
×
EBIT Margin
0.349
EBIT / Rev
×
Asset Turnover
0.381
Rev / Assets
×
Equity Multiplier
1.292
Assets / Equity
=
ROE
14.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. REGN's ROE of 14.6% is driven by Asset Turnover (0.381), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
3.83%
Fair P/E
16.16x
Intrinsic Value
$663.85
Price/Value
1.16x
Margin of Safety
-16.39%
Premium
16.39%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with REGN's realized 3.8% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. REGN trades at a 16% premium to its adjusted intrinsic value of $663.85, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 16.2x compares to the current market P/E of 15.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$638.88
Median 1Y
$647.34
5th Pctile
$389.47
95th Pctile
$1076.99
Ann. Volatility
32.4%
Analyst Target
$827.78
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Daniel P. Van
Plew Executive Vice President and General Manager, Industrial Operations and Product Supply
$983,382 $2,699,728 $8,780,263
Andrew J. Murphy,
Ph.D. Executive Vice President, Co-Chief Scientific Officer
$819,672 $2,699,728 $8,477,119
Joseph J. LaRosa
Executive Vice President, General Counsel and Secretary
$916,062 $1,799,334 $7,458,970
Leonard S. Schleifer,
M.D., Ph.D. Board co-Chair, President and Chief Executive Officer
$1,979,922 $— $7,280,549
Christopher Fenimore President,
Vice President, Finance and Chief Financial Officer
$725,000 $2,199,751 $6,985,364
George D. Yancopoulos,
M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer
$1,979,922 $— $6,949,469

CEO Pay Ratio

42:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,280,549
Avg Employee Cost (SGA/emp): $175,211
Employees: 15,410

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
15,410
+2.0% YoY
Revenue / Employee
$930,753
Rev: $14,342,900,000
Profit / Employee
$292,336
NI: $4,504,900,000
SGA / Employee
$175,211
Avg labor cost proxy
R&D / Employee
$379,637
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 56.1% 63.3% 54.2% 53.3% 38.2% 36.0% 20.9% 20.2% 20.8% 19.3% 16.3% 15.9% 17.8% 19.1% 16.0% 16.3% 16.1% 16.5% 14.9% 14.6% 14.60%
ROA 38.8% 43.8% 37.9% 37.2% 26.7% 25.2% 15.9% 15.3% 15.7% 14.6% 12.7% 12.4% 13.9% 14.9% 12.5% 12.7% 12.6% 12.9% 11.5% 11.3% 11.30%
ROIC 56.6% 64.1% 49.1% 50.2% 40.2% 36.4% 26.0% 24.7% 23.3% 23.5% 22.6% 21.6% 21.6% 21.3% 16.0% 15.0% 15.2% 14.2% 12.2% 12.3% 12.28%
ROCE 50.5% 56.0% 43.6% 42.7% 29.8% 28.3% 18.9% 18.1% 18.6% 17.1% 14.4% 13.9% 15.7% 17.0% 14.3% 14.9% 14.5% 15.3% 14.6% 14.4% 14.38%
Gross Margin 85.1% 84.8% 78.7% 83.8% 87.0% 86.0% 85.2% 82.4% 83.9% 83.9% 81.7% 86.2% 86.5% 86.8% 85.1% 84.7% 85.6% 86.1% 84.9% 81.4% 81.43%
Operating Margin 65.1% 53.5% 53.3% 43.4% 45.7% 41.7% 38.5% 31.7% 32.2% 36.0% 30.6% 23.9% 30.2% 31.7% 26.1% 19.5% 29.4% 27.3% 22.7% 17.8% 17.83%
Net Margin 60.3% 47.3% 45.0% 32.8% 29.8% 44.8% 35.1% 25.9% 30.7% 30.0% 33.8% 23.0% 40.4% 36.0% 24.2% 26.7% 37.9% 38.9% 21.7% 20.2% 20.17%
EBITDA Margin 74.7% 55.1% 52.3% 38.8% 36.8% 55.1% 42.2% 30.8% 38.2% 36.7% 37.2% 26.4% 49.7% 43.8% 28.9% 34.4% 45.1% 51.1% 30.9% 26.8% 26.83%
FCF Margin 13.7% 39.7% 40.6% 48.1% 55.3% 37.0% 36.3% 29.5% 32.8% 35.2% 29.1% 30.3% 23.8% 24.4% 25.3% 21.4% 27.0% 29.2% 28.4% 27.9% 27.85%
OCF Margin 18.3% 43.9% 44.1% 51.6% 59.4% 41.3% 41.2% 34.6% 37.4% 39.9% 35.0% 36.2% 30.2% 30.7% 31.1% 28.1% 33.4% 35.6% 34.7% 33.6% 33.60%
ROE 3Y Avg snapshot only 14.78%
ROE 5Y Avg snapshot only 21.01%
ROA 3Y Avg snapshot only 11.49%
ROIC 3Y Avg snapshot only 15.07%
ROIC Economic snapshot only 9.25%
Cash ROA snapshot only 12.36%
Cash ROIC snapshot only 19.77%
CROIC snapshot only 16.39%
NOPAT Margin snapshot only 20.86%
Pretax Margin snapshot only 34.56%
R&D / Revenue snapshot only 41.97%
SGA / Revenue snapshot only 18.20%
SBC / Revenue snapshot only 6.67%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 9.92 9.80 8.80 9.90 11.78 14.39 18.85 22.27 18.93 23.25 25.14 28.56 27.91 26.10 18.27 15.61 12.75 13.15 18.42 18.81 15.021
P/S Ratio 4.97 5.06 4.42 4.76 4.71 5.64 6.72 7.53 6.42 7.09 7.58 8.41 8.94 8.77 5.68 4.99 4.00 4.23 5.79 5.58 4.412
P/B Ratio 5.58 6.22 3.79 4.19 3.57 4.12 3.61 4.11 3.59 4.10 3.83 4.24 4.64 4.68 2.75 2.39 1.94 2.05 2.65 2.66 2.114
P/FCF 36.34 12.74 10.89 9.90 8.52 15.23 18.49 25.49 19.60 20.16 26.07 27.72 37.60 35.97 22.41 23.25 14.79 14.49 20.33 20.03 20.026
P/OCF 27.09 11.54 10.04 9.23 7.93 13.64 16.31 21.76 17.18 17.77 21.64 23.25 29.63 28.60 18.24 17.77 11.99 11.87 16.67 16.60 16.601
EV/EBITDA 8.02 8.08 7.04 7.97 9.56 11.59 14.59 17.32 14.57 18.07 19.44 22.43 22.02 20.60 13.97 11.56 9.32 9.43 13.25 13.46 13.458
EV/Revenue 4.90 5.00 4.24 4.58 4.50 5.42 6.31 7.12 6.03 6.70 6.96 7.79 8.34 8.19 5.23 4.54 3.56 3.78 5.37 5.18 5.182
EV/EBIT 8.31 8.35 7.26 8.22 10.00 12.19 15.61 18.67 15.76 19.73 21.36 24.81 24.17 22.52 15.37 12.70 10.29 10.39 14.61 14.85 14.854
EV/FCF 35.82 12.57 10.43 9.52 8.14 14.64 17.35 24.11 18.38 19.06 23.93 25.67 35.06 33.56 20.66 21.16 13.15 12.97 18.89 18.61 18.607
Earnings Yield 10.1% 10.2% 11.4% 10.1% 8.5% 6.9% 5.3% 4.5% 5.3% 4.3% 4.0% 3.5% 3.6% 3.8% 5.5% 6.4% 7.8% 7.6% 5.4% 5.3% 5.32%
FCF Yield 2.8% 7.9% 9.2% 10.1% 11.7% 6.6% 5.4% 3.9% 5.1% 5.0% 3.8% 3.6% 2.7% 2.8% 4.5% 4.3% 6.8% 6.9% 4.9% 5.0% 4.99%
PEG Ratio snapshot only 8.146
Price/Tangible Book snapshot only 2.774
EV/OCF snapshot only 15.424
EV/Gross Profit snapshot only 6.129
Acquirers Multiple snapshot only 21.304
Shareholder Yield snapshot only 4.99%
Graham Number snapshot only $517.88
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.63 3.63 3.56 3.56 3.56 3.56 5.06 5.06 5.06 5.06 5.69 5.69 5.69 5.69 4.73 4.73 4.73 4.73 4.13 4.13 4.126
Quick Ratio 2.91 2.91 3.07 3.07 3.07 3.07 4.29 4.29 4.29 4.29 4.94 4.94 4.94 4.94 3.95 3.95 3.95 3.95 3.39 3.39 3.393
Debt/Equity 0.24 0.24 0.14 0.14 0.14 0.14 0.12 0.12 0.12 0.12 0.10 0.10 0.10 0.10 0.09 0.09 0.09 0.09 0.09 0.09 0.087
Net Debt/Equity -0.08 -0.08 -0.16 -0.16 -0.16 -0.16 -0.22 -0.22 -0.22 -0.22 -0.31 -0.31 -0.31 -0.31 -0.21 -0.21 -0.21 -0.21 -0.19 -0.19 -0.189
Debt/Assets 0.16 0.16 0.11 0.11 0.11 0.11 0.09 0.09 0.09 0.09 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.07 0.07 0.067
Debt/EBITDA 0.36 0.32 0.28 0.28 0.40 0.42 0.51 0.53 0.52 0.56 0.58 0.59 0.53 0.49 0.51 0.49 0.50 0.47 0.47 0.47 0.471
Net Debt/EBITDA -0.12 -0.11 -0.31 -0.32 -0.45 -0.47 -0.96 -0.99 -0.96 -1.04 -1.73 -1.79 -1.59 -1.48 -1.19 -1.14 -1.16 -1.10 -1.01 -1.03 -1.027
Interest Coverage 104.12 139.74 163.75 163.24 116.35 108.62 82.80 73.97 69.61 61.70 58.52 57.85 69.47 79.88 87.59 105.27 134.19 123.21 120.42 108.44 108.435
Equity Multiplier 1.56 1.56 1.36 1.36 1.36 1.36 1.29 1.29 1.29 1.29 1.27 1.27 1.27 1.27 1.29 1.29 1.29 1.29 1.30 1.30 1.298
Cash Ratio snapshot only 1.970
Debt Service Coverage snapshot only 119.685
Cash to Debt snapshot only 3.180
FCF to Debt snapshot only 1.536
Defensive Interval snapshot only 582.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.77 0.85 0.75 0.78 0.67 0.64 0.45 0.45 0.46 0.48 0.42 0.42 0.43 0.44 0.40 0.40 0.40 0.40 0.37 0.38 0.381
Inventory Turnover 1.13 1.25 1.41 1.46 1.26 1.20 0.81 0.85 0.91 0.97 0.90 0.85 0.84 0.82 0.70 0.71 0.72 0.73 0.67 0.73 0.733
Receivables Turnover 3.83 4.18 3.17 3.25 2.80 2.70 2.14 2.18 2.23 2.30 2.39 2.38 2.45 2.52 2.39 2.37 2.39 2.40 2.40 2.50 2.496
Payables Turnover 4.23 4.66 5.24 5.44 4.68 4.46 3.07 3.20 3.44 3.67 3.74 3.53 3.49 3.40 2.82 2.87 2.94 2.98 2.43 2.67 2.668
DSO 95 87 115 112 130 135 170 168 164 158 153 153 149 145 153 154 153 152 152 146 146.2 days
DIO 322 292 259 250 290 304 449 430 401 376 407 430 436 447 525 517 504 497 546 498 497.7 days
DPO 86 78 70 67 78 82 119 114 106 100 98 103 105 107 129 127 124 122 150 137 136.8 days
Cash Conversion Cycle 331 301 305 295 342 358 501 484 458 435 462 480 480 485 548 544 533 527 548 507 507.1 days
Fixed Asset Turnover snapshot only 2.914
Operating Cycle snapshot only 643.9 days
Cash Velocity snapshot only 1.734
Capital Intensity snapshot only 2.718
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 67.6% 70.6% 89.1% 79.5% 14.9% 1.2% -24.3% -25.1% -10.9% -4.5% 7.8% 5.9% 6.5% 5.7% 8.3% 7.5% 5.4% 2.9% 1.0% 5.9% 5.92%
Net Income 1.1% 1.2% 1.3% 98.2% -8.4% -23.2% -46.3% -47.3% -24.4% -25.7% -8.9% -7.8% 0.5% 16.6% 11.6% 16.6% 3.2% -1.6% 2.1% -1.7% -1.69%
EPS 1.2% 1.2% 1.3% 93.6% -10.9% -22.5% -46.7% -47.7% -24.3% -26.1% -8.7% -8.6% -0.8% 13.8% 11.6% 20.7% 9.6% 6.6% 8.1% 1.5% 1.51%
FCF -30.2% 2.4% 2.3% 2.9% 3.6% -5.7% -32.2% -54.0% -47.2% -9.3% -13.8% 8.8% -22.7% -26.7% -5.7% -24.0% 19.8% 23.0% 13.4% 37.6% 37.58%
EBITDA 1.2% 1.2% 1.4% 1.0% -11.4% -23.5% -45.6% -46.4% -21.7% -24.2% -10.8% -10.6% -2.5% 13.3% 13.3% 21.5% 6.1% 3.8% 9.4% 3.9% 3.93%
Op. Income 1.4% 1.4% 1.5% 1.3% 6.0% -13.6% -42.6% -46.8% -35.6% -29.6% -16.6% -16.9% -10.4% -10.9% -6.8% -4.9% -5.9% -9.0% -10.3% -5.3% -5.27%
OCF Growth snapshot only 26.80%
Asset Growth snapshot only 7.41%
Equity Growth snapshot only 6.48%
Debt Growth snapshot only 0.06%
Shares Change snapshot only -3.15%
Dividend Growth snapshot only 2.99%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 25.9% 28.6% 33.8% 35.9% 29.6% 27.5% 22.9% 20.8% 19.7% 18.2% 15.6% 12.5% 2.9% 0.7% -4.0% -5.2% -0.0% 1.3% 5.6% 6.4% 6.45%
Revenue 5Y 21.6% 23.4% 27.0% 27.1% 22.1% 20.0% 15.7% 15.3% 15.4% 15.5% 14.3% 14.8% 15.6% 15.9% 16.7% 15.0% 14.0% 12.4% 11.0% 10.2% 10.16%
EPS 3Y 59.1% 57.8% 49.6% 49.5% 40.5% 36.4% 27.2% 22.8% 14.3% 8.3% 3.5% -2.6% -12.6% -13.3% -18.4% -16.8% -6.3% -3.6% 3.3% 3.8% 3.83%
EPS 5Y 55.0% 55.7% 56.5% 53.0% 38.1% 34.2% 29.8% 24.2% 22.1% 17.6% 10.3% 9.8% 15.8% 16.4% 15.9% 15.4% 10.2% 9.0% 6.0% 2.5% 2.54%
Net Income 3Y 57.4% 57.3% 48.9% 48.4% 40.1% 35.8% 27.0% 22.4% 12.9% 8.1% 4.0% -1.2% -11.4% -12.7% -18.2% -17.2% -7.8% -5.2% 1.3% 1.9% 1.88%
Net Income 5Y 53.5% 55.0% 55.8% 52.5% 37.6% 33.3% 29.3% 24.0% 22.0% 17.3% 10.1% 9.7% 15.9% 16.8% 15.8% 14.6% 8.4% 7.7% 5.1% 2.0% 2.01%
EBITDA 3Y 44.0% 47.7% 52.4% 51.9% 42.9% 37.9% 25.4% 22.1% 14.4% 9.0% 4.6% -1.1% -12.2% -13.1% -18.1% -16.5% -6.8% -3.8% 3.4% 4.1% 4.14%
EBITDA 5Y 41.4% 44.8% 46.5% 43.5% 29.9% 25.9% 18.5% 16.2% 15.7% 13.3% 11.4% 10.9% 17.4% 17.6% 14.8% 14.6% 9.2% 8.8% 7.2% 4.1% 4.06%
Gross Profit 3Y 23.0% 25.5% 29.6% 32.2% 26.6% 25.5% 23.1% 20.7% 19.7% 17.8% 15.1% 12.4% 2.8% 1.0% -2.9% -4.1% 1.0% 2.2% 5.6% 6.2% 6.22%
Gross Profit 5Y 19.8% 21.3% 24.3% 24.3% 19.7% 17.9% 14.3% 13.9% 13.6% 13.6% 12.2% 13.2% 14.4% 15.4% 17.0% 15.1% 14.3% 12.6% 11.4% 10.3% 10.26%
Op. Income 3Y 42.9% 47.0% 52.3% 55.0% 49.0% 42.1% 32.4% 25.9% 18.1% 13.8% 6.2% 0.3% -15.1% -18.5% -23.6% -25.1% -18.4% -17.0% -11.3% -9.2% -9.21%
Op. Income 5Y 39.9% 43.8% 46.4% 44.8% 33.2% 27.9% 19.8% 17.0% 14.8% 14.1% 11.1% 10.5% 13.8% 12.5% 12.5% 9.5% 6.8% 3.6% 0.0% -1.9% -1.87%
FCF 3Y 1.1% 49.0% 53.3% 55.9% 60.4% 36.5% 30.3% 28.9% 19.6% 42.8% 23.9% 25.1% 23.7% -14.4% -18.0% -27.5% -21.2% -6.5% -2.7% 4.4% 4.37%
FCF 5Y 10.0% 45.1% 46.7% 43.0% 51.7% 44.6% 33.7% 23.6% 20.5% 23.1% 16.0% 13.7% 11.0% 11.1% 12.5% 12.1% 9.7% 21.3% 15.3% 15.4% 15.42%
OCF 3Y 4.4% 43.0% 47.8% 51.0% 55.1% 33.7% 27.3% 24.3% 16.6% 33.9% 20.6% 22.3% 21.5% -10.6% -14.5% -22.6% -17.5% -3.6% -0.2% 5.4% 5.40%
OCF 5Y 7.0% 34.0% 36.9% 36.7% 44.2% 38.4% 30.9% 22.2% 18.9% 20.8% 15.9% 13.9% 12.4% 12.4% 12.7% 12.1% 9.7% 18.5% 13.7% 14.1% 14.13%
Assets 3Y 25.1% 25.1% 29.4% 29.4% 29.4% 29.4% 25.4% 25.4% 25.4% 25.4% 24.4% 24.4% 24.4% 24.4% 14.1% 14.1% 14.1% 14.1% 11.6% 11.6% 11.56%
Assets 5Y 25.1% 25.1% 29.5% 29.5% 29.5% 29.5% 27.2% 27.2% 27.2% 27.2% 23.0% 23.0% 23.0% 23.0% 20.6% 20.6% 20.6% 20.6% 18.8% 18.8% 18.77%
Equity 3Y 21.5% 21.5% 28.9% 28.9% 28.9% 28.9% 26.9% 26.9% 26.9% 26.9% 33.1% 33.1% 33.1% 33.1% 16.1% 16.1% 16.1% 16.1% 11.3% 11.3% 11.31%
Book Value 3Y 22.9% 21.9% 29.5% 29.9% 29.3% 29.5% 27.0% 27.3% 28.4% 27.1% 32.4% 31.3% 31.3% 32.2% 15.9% 16.7% 18.0% 18.1% 13.5% 13.4% 13.44%
Dividend 3Y 61.6% 61.65%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.74 0.73 0.68 0.72 0.85 0.83 0.63 0.64 0.78 0.78 0.54 0.52 0.69 0.67 0.44 0.37 0.66 0.74 0.93 0.97 0.972
Earnings Stability 0.80 0.77 0.74 0.79 0.86 0.77 0.55 0.54 0.60 0.43 0.22 0.19 0.25 0.18 0.06 0.04 0.00 0.00 0.04 0.09 0.087
Margin Stability 0.96 0.96 0.95 0.95 0.96 0.96 0.97 0.97 0.96 0.96 0.96 0.97 0.97 0.98 0.98 0.99 0.99 0.99 0.98 0.99 0.991
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 1.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.97 0.91 0.81 0.81 0.90 0.90 0.96 0.97 1.00 0.93 0.95 0.93 0.99 0.99 0.99 0.99 0.993
Earnings Smoothness 0.30 0.24 0.21 0.34 0.91 0.74 0.40 0.38 0.72 0.71 0.91 0.92 0.99 0.85 0.89 0.85 0.97 0.98 0.98 0.98 0.983
ROE Trend 0.31 0.37 0.18 0.14 -0.11 -0.17 -0.18 -0.21 -0.24 -0.28 -0.16 -0.16 -0.08 -0.05 -0.02 -0.01 -0.03 -0.02 -0.01 -0.01 -0.009
Gross Margin Trend -0.02 -0.01 -0.02 -0.02 -0.02 -0.02 0.02 0.02 0.01 -0.00 -0.01 -0.00 0.01 0.02 0.02 0.01 0.01 0.01 0.01 -0.00 -0.003
FCF Margin Trend -0.17 0.15 0.14 0.25 0.32 0.07 0.04 -0.06 -0.02 -0.03 -0.09 -0.08 -0.20 -0.12 -0.07 -0.09 -0.01 -0.01 0.01 0.02 0.020
Sustainable Growth Rate 56.1% 63.3% 54.2% 53.3% 38.2% 36.0% 20.9% 20.2% 20.8% 19.3% 16.3% 15.9% 17.8% 19.1% 16.0% 15.9% 15.4% 15.5% 13.6% 13.4% 13.36%
Internal Growth Rate 63.5% 77.8% 61.1% 59.4% 36.4% 33.7% 18.9% 18.1% 18.7% 17.1% 14.5% 14.1% 16.1% 17.6% 14.2% 14.2% 13.7% 13.8% 11.8% 11.5% 11.53%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.37 0.85 0.88 1.07 1.49 1.06 1.16 1.02 1.10 1.31 1.16 1.23 0.94 0.91 1.00 0.88 1.06 1.11 1.11 1.13 1.133
FCF/OCF 0.75 0.91 0.92 0.93 0.93 0.90 0.88 0.85 0.88 0.88 0.83 0.84 0.79 0.80 0.81 0.76 0.81 0.82 0.82 0.83 0.829
FCF/Net Income snapshot only 0.939
OCF/EBITDA snapshot only 0.873
CapEx/Revenue 4.7% 4.1% 3.4% 3.5% 4.1% 4.3% 4.8% 5.1% 4.6% 4.7% 6.0% 5.8% 6.4% 6.3% 5.8% 6.6% 6.3% 6.4% 6.3% 5.7% 5.75%
CapEx/Depreciation snapshot only 1.588
Accruals Ratio 0.25 0.07 0.05 -0.03 -0.13 -0.01 -0.02 -0.00 -0.02 -0.05 -0.02 -0.03 0.01 0.01 -0.00 0.02 -0.01 -0.01 -0.01 -0.02 -0.015
Sloan Accruals snapshot only -0.041
Cash Flow Adequacy snapshot only 4.069
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.3% 0.5% 0.4% 0.4% 0.57%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.84 $1.72 $2.59 $3.44 $3.48 $3.64
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.1% 4.2% 6.1% 8.2% 8.5% 8.46%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.1% 4.8% 6.7% 9.1% 9.0% 9.01%
Total Payout Ratio 22.2% 23.4% 33.2% 33.7% 48.4% 62.5% 58.3% 68.8% 73.9% 70.4% 74.3% 62.7% 60.9% 57.8% 71.8% 89.3% 95.4% 93.3% 96.1% 93.9% 93.91%
Div. Increase Streak 0 0 0 0 1 0
Chowder Number 2.99 2.995
Buyback Yield 2.2% 2.4% 3.8% 3.4% 4.1% 4.3% 3.1% 3.1% 3.9% 3.0% 3.0% 2.2% 2.2% 2.2% 3.9% 5.6% 7.2% 6.6% 4.8% 4.5% 4.54%
Net Buyback Yield 1.1% 0.6% 1.4% 0.7% 0.8% 2.2% 1.2% 1.5% 2.3% 1.7% 1.8% 1.0% 0.8% 0.8% 2.1% 4.4% 6.4% 6.3% 4.0% 3.7% 3.65%
Total Shareholder Return 1.1% 0.6% 1.4% 0.7% 0.8% 2.2% 1.2% 1.5% 2.3% 1.7% 1.8% 1.0% 0.8% 0.8% 2.1% 4.5% 6.7% 6.7% 4.4% 4.1% 4.10%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.86 0.87 0.87 0.87 0.90 0.89 0.89 0.90 0.90 0.91 0.94 0.95 0.94 0.94 0.92 0.90 0.91 0.89 0.86 0.86 0.858
Interest Burden (EBT/EBIT) 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.98 0.98 0.98 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.991
EBIT Margin 0.59 0.60 0.58 0.56 0.45 0.44 0.40 0.38 0.38 0.34 0.33 0.31 0.35 0.36 0.34 0.36 0.35 0.36 0.37 0.35 0.349
Asset Turnover 0.77 0.85 0.75 0.78 0.67 0.64 0.45 0.45 0.46 0.48 0.42 0.42 0.43 0.44 0.40 0.40 0.40 0.40 0.37 0.38 0.381
Equity Multiplier 1.45 1.45 1.43 1.43 1.43 1.43 1.32 1.32 1.32 1.32 1.28 1.28 1.28 1.28 1.28 1.28 1.28 1.28 1.29 1.29 1.292
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $56.01 $61.42 $71.34 $70.15 $49.88 $47.61 $38.06 $36.69 $37.74 $35.19 $34.74 $33.52 $37.45 $40.06 $38.78 $40.46 $41.06 $42.71 $41.91 $41.07 $41.07
Book Value/Share $99.51 $96.80 $165.80 $165.95 $164.64 $166.39 $198.81 $198.81 $198.98 $199.86 $228.23 $225.66 $225.07 $223.52 $257.94 $263.97 $270.29 $273.82 $290.76 $290.22 $302.15
Tangible Book/Share $99.51 $96.80 $165.74 $165.89 $164.58 $166.33 $190.78 $190.78 $190.94 $191.79 $219.11 $216.63 $216.07 $214.58 $247.85 $253.64 $259.71 $263.11 $279.07 $278.55 $278.55
Revenue/Share $111.77 $118.90 $141.98 $145.96 $124.80 $121.54 $106.78 $108.51 $111.24 $115.50 $115.27 $113.81 $116.89 $119.17 $124.80 $126.67 $130.89 $132.91 $133.42 $138.53 $143.46
FCF/Share $15.28 $47.25 $57.68 $70.17 $69.02 $44.99 $38.81 $32.06 $36.46 $40.61 $33.51 $34.53 $27.80 $29.07 $31.61 $27.16 $35.40 $38.75 $37.96 $38.58 $39.95
OCF/Share $20.50 $52.15 $62.56 $75.28 $74.14 $50.24 $43.99 $37.55 $41.60 $46.07 $40.37 $41.17 $35.27 $36.55 $38.84 $35.55 $43.68 $47.30 $46.32 $46.54 $48.20
Cash/Share $32.37 $31.49 $50.31 $50.35 $49.95 $50.48 $67.91 $67.91 $67.97 $68.27 $95.30 $94.22 $93.98 $93.33 $79.20 $81.05 $82.99 $84.07 $80.05 $79.90 $84.17
EBITDA/Share $68.22 $73.56 $85.42 $83.85 $58.73 $56.82 $46.14 $44.61 $46.01 $42.83 $41.24 $39.52 $44.26 $47.35 $46.73 $49.71 $49.92 $53.29 $54.12 $53.34 $53.34
Debt/Share $24.33 $23.67 $23.85 $23.87 $23.68 $23.93 $23.70 $23.70 $23.72 $23.82 $23.75 $23.48 $23.42 $23.26 $23.76 $24.32 $24.90 $25.23 $25.17 $25.12 $25.12
Net Debt/Share $-8.04 $-7.83 $-26.46 $-26.48 $-26.27 $-26.55 $-44.22 $-44.22 $-44.26 $-44.45 $-71.55 $-70.74 $-70.55 $-70.07 $-55.43 $-56.73 $-58.09 $-58.84 $-54.88 $-54.78 $-54.78
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 7.799
Altman Z-Prime snapshot only 15.341
Piotroski F-Score 7 6 5 6 5 6 6 5 6 5 7 6 5 6 8 6 5 5 5 6 6
Beneish M-Score -0.29 -1.75 -1.36 -1.96 -1.85 -1.86 -2.71 -2.57 -2.60 -2.69 -2.51 -2.61 -2.42 -2.40 -2.24 -2.12 -2.21 -2.26 -2.52 -2.47 -2.468
Ohlson O-Score snapshot only -11.582
ROIC (Greenblatt) snapshot only 27.72%
Net-Net WC snapshot only $80.97
EVA snapshot only $577149100.43
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AAA
Credit Score 97.04 97.01 96.92 96.90 97.16 97.14 97.45 96.86 97.09 96.90 96.85 96.75 96.92 96.77 97.06 96.93 96.91 96.55 96.88 96.76 96.760
Credit Grade snapshot only 1
Credit Trend snapshot only -0.169
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 95
Sector Credit Rank snapshot only 92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms